NG
FBT icon

Novem Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Novem Group’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275K Buy
1,111
+33
+3% +$7.11K 0.03% 372
2026
Q1 		$216K Buy
+1,078
New +$223K 0.02% 400

Other funds holding FBT

NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
NC
NewSquare Capital Newtown Square, Pennsylvania $1.35B AUM 34.37% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
HFM
Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return
AFA
Arlington Financial Advisors Santa Barbara, California $787M AUM 22.93% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Novem Group's FBT Position: Q2 2026 in Review

Novem Group increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3.1% in Q2 2026, buying an estimated $7.11K and bringing the position to 1,111 shares worth $275K. The position accounts for 0.03% of the portfolio, ranked #372.

Novem Group first reported a position in FBT in Q1 2026 and has held it in 2 quarters since. 123 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Novem Group held 1,111 shares of First Trust NYSE Arca Biotechnology Index Fund worth $275K as of Q2 2026.
  • Novem Group bought 33 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $7.11K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Novem Group's portfolio in Q2 2026, its #372 holding.
  • Novem Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2026 and has held it in 2 quarters since.
  • 123 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.